Parallel Advisors’s Savara SVRA Stock Holding History

Parallel Advisors’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-193	Closed	-$818	–	3614
2024 Q3	$818	Buy	+193	New	+$852	﹤0.01%	3082

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Parallel Advisors's SVRA Position: Q4 2024 in Review

Parallel Advisors sold out of Savara (SVRA) in Q4 2024, closing a stake of 193 shares — an estimated $818 sold.

Parallel Advisors first reported a position in SVRA in Q3 2024 and held it in 1 quarter. The position peaked at $818 in Q3 2024. 134 funds tracked by Wall St. Rank hold SVRA as of Q4 2024.

Parallel Advisors reported no remaining Savara position as of Q4 2024 after selling out during the quarter.
Parallel Advisors sold 193 Savara shares in Q4 2024, an estimated $818.
Parallel Advisors first reported a position in Savara in Q3 2024 and held it in 1 quarter.
Parallel Advisors's Savara position peaked at $818 in Q3 2024.
134 funds tracked by Wall St. Rank held Savara as of Q4 2024.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.